|
COPYRIGHT 2006 Asia Pulse Pty Ltd
An executive briefing on Health for March 31, 2006, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.
INDIA'S AUROBINDO PHARMA GETS USFDA NOD FOR ZIDOVUDINE CAPSULES
MUMBAI - Hyderabad-based Aurobindo Pharma Limited (BSE:524804) has received USFDA approval to market Zidovudine capsules, intended to use for the treatment of HIV-1 infection, in that country.
This approval would pave way for the company to qualify under the President's Emergency Plan for AIDS Relief (PEPFAR) programme, Aurobindo Pharma informed the Bombay Stock Exchange.
AUSTRALIA'S COLES MYER TESTS PHARMACY WATERS WITH US$34 MLN BUY
PERTH - Retailer Coles Myer Ltd...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
